ClinicalTrials.govpublic full text
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
gastric cancer, gastroesophageal-junction cancer, advanced cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967973
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.